Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1Classical hematology 1

Conditions

Venous Thromboembolism 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Thrombosis 1Ovarian Neoplasms 1Neoplasms 1Endometrial Neoplasms 1

Interventions

apixaban 22Rivaroxaban 16Dalteparin 16Enoxaparin 11Heparin, Low-Molecular-Weight 10Tinzaparin 8Aspirin 8Fondaparinux 4Dabigatran 4edoxaban 3Warfarin 3Nadroparin 3bemiparin 2abelacimab 2Rosuvastatin Calcium 2Observation 2MAA868 2sotorasib 1ribociclib 1reviparin 1palbociclib 1isoquercitrin 1enoxaparin sodium 1certoparin 1calcium heparin 1betrixaban 1argatroban 1acarboxyprothrombin 1abemaciclib 1Tacrolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Venous Thromboembolism × Anticoagulants × Classical hematology × Clear all
NCT06284343 2024-09-19

GynCAT

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Recruiting
1,800 enrolled
Classical hematologyGynecologic

Uterine Cervical Neoplasms, Neoplasms, Ovarian Neoplasms, Thrombosis, Vaginal Neoplasms, Endometrial Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡